Zinc Fingers nuclease News and Research

RSS
Sangamo BioSciences initiates two new clinical trials of ZFP Therapeutics

Sangamo BioSciences initiates two new clinical trials of ZFP Therapeutics

Data from Phase 1 safety study of SB-728-T announced

Data from Phase 1 safety study of SB-728-T announced

Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS

Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS

Sigma-Aldrich launches SAGEspeed, a program for developing human disease models in rodents

Sigma-Aldrich launches SAGEspeed, a program for developing human disease models in rodents

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Sigma-Aldrich and Sangamo Biosciences extend license agreement for ZFP technology

Doris Duke Innovations award for sickle cell disease research

Doris Duke Innovations award for sickle cell disease research

FDA accepts Sangamo's IND for repeat-dosing in Phase 1 clinical trial of SB-728-T ZFN-based therapeutic

FDA accepts Sangamo's IND for repeat-dosing in Phase 1 clinical trial of SB-728-T ZFN-based therapeutic

Zinc finger nucleases utilized for modifying hESCs and hiPSCs

Zinc finger nucleases utilized for modifying hESCs and hiPSCs

Sigma-Aldrich scientists to leverage proprietary gene editing technology to develop genetically-engineered rodent research models

Sigma-Aldrich scientists to leverage proprietary gene editing technology to develop genetically-engineered rodent research models

A new technique for modifying plant genes

A new technique for modifying plant genes

Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

DNA repair kit announced by scientists

DNA repair kit announced by scientists